Advertisement

PharmacoEconomics & Outcomes News

, Volume 807, Issue 1, pp 19–19 | Cite as

Is risk-stratified breast cancer screening a better option?

Clinical study

References

  1. 1.
    Pashayan N, et al. Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer. A Life-Table Model. JAMA Oncology : 5 Jul 2018. Available from: URL: http://dx.doi.org/10.1001/jamaoncol.2018.1901.Google Scholar
  2. 2.
    Roberts MC. Implementation Challenges for Risk-Stratified Screening in the Era of Precision Medicine. JAMA Oncology : 5 Jul 2018. Available from: URL: http://dx.doi.org/10.1001/jamaoncol.2018.1940.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations